Cambridge Innovation Capital is a leading UK venture capital firm based in Cambridge that focuses on commercializing science and technology emerging from the University of Cambridge ecosystem. The firm has become one of the core financial institutions supporting the translation of academic research into venture-scale businesses.

Its portfolio includes major companies such as CMR Surgical and Pragmatic Semiconductor, and it is known for providing patient capital and hands-on support to deep-tech and life sciences startups. Although not exclusively neurotech-focused, CIC is highly relevant for neurotech companies emerging from university research environments, especially those with advanced diagnostics, therapeutics, or AI-health applications.

The firm’s main geographic focus is Cambridge and the broader UK ecosystem. It is particularly important for companies seeking institutional support at the point where academic science becomes a commercial platform.